Editas Medicine Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Editas Medicine, Inc. (EDIT) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.130.320.140.200.400.460.37
Short-Term Investments0.140.200.200.300.260.000.00
Cash & Short-Term Investments0.270.320.340.500.400.460.37
Accounts Receivable0.020.010.010.000.010.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.000.010.010.010.010.000.00
Total Current Assets0.290.340.360.510.420.460.37
Non-Current Assets
Property, Plant & Equipment (Net)0.050.050.060.040.040.030.04
Long-Term Investments0.000.100.090.120.110.000.00
Other Non-Current Assets0.010.010.010.010.000.010.01
Total Non-Current Assets0.050.160.160.170.150.030.05
Total Assets0.340.500.510.680.570.510.42
Current Liabilities
Accounts Payable0.010.040.010.010.030.030.01
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.020.020.030.020.020.000.00
Deferred Revenue0.010.010.010.010.020.000.00
Other Current Liabilities0.000.010.010.010.010.000.00
Total Current Liabilities0.080.060.060.050.060.060.04
Non-Current Liabilities
Long-Term Debt0.020.020.030.020.020.020.03
Other Non-Current Liabilities0.000.000.070.070.030.000.00
Total Non-Current Liabilities0.130.090.090.080.120.190.15
Total Liabilities0.210.150.150.120.180.250.18
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.47-1.23-1.08-0.86-0.67-0.55-0.42
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.601.581.441.411.060.810.65
Shares Outstanding0.080.080.070.070.000.000.00
Total Stockholders' Equity0.130.350.360.550.390.260.24
Total Liabilities & Equity0.340.500.510.680.570.510.42